Today, in the development of neuroprotective drugs for the treatment of stroke, special attention is paid to peptides that act in several key areas: (1) in blocking the cascade of pathological processes caused by the restriction of blood flow to the brain tissues, (2) in preventing repeated violations of the blood supply to the brain and complications that aggravate the course of the disease, and (3) in restoring nerve tissue and brain function after ischemia [24,25,26]
Avoid injecting the same spot repeatedly
Convenience One injection instead of two
These in vitro findings were corroborated by clinical observations, where subjects treated with DEC-containing serum exhibited significant improvements in skin lightness and reduced yellowness, with a high participant satisfaction rate of 97%
demonstrated that METTL3, a key m 6 A methyltransferase, increases N 6 -methyladenosine (m 6 A) modification of SLC7A11 mRNA, thereby enhancing SLC7A11 stability and translation through recruitment of the m 6 A reader YTH N 6 -methyladenosine RNA binding protein 1 (YTHDF1)
Some animals may object to the daily eye drops, making this route of administration ineffective